1
|
Jauslin AS, Kellett J, Brabrand M, Simon NR, Rueegg M, Twerenbold R, Osswald S, Bassetti S, Tschudin-Sutter S, Siegemund M, Rentsch K, Bingisser R, Nickel CH. D-dimer levels for Risk Stratification in Patients with Suspected COVID-19 - A Prospective Observational Study. Acute Med 2021; 20:193-203. [PMID: 34679137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
BACKGROUND Elevated D-dimer levels have been observed in COVID-19 and are of prognostic value, but have not been compared to an appropriate control group. METHODS Observational cohort study including emergency patients with suspected or confirmed COVID-19. Logistic regression defined the association of D-dimer levels, COVID-19 positivity, age, and gender with 30-day-mortality. RESULTS 953 consecutive patients (median age 58, 43% women) presented with suspected COVID-19: 12 (7.4%) patients with confirmed SARS-CoV-2-infection died, compared with 28 (3.5%) patients without SARS-CoV-2-infection. Overall, most (56%) patients had elevated D-dimer levels (≥0.5mg/l). Age (OR 1.07, CI 1.05-1.10), D-dimer levels ≥0.5mg/l (OR 2.44, CI 0.98-7.39), and COVID-19 (OR 2.79, CI 1.28-5.80) were associated with 30-day-mortality. CONCLUSION D-dimer levels are effective prognosticators in both patient groups.
Collapse
Affiliation(s)
- A S Jauslin
- MD, Emergency Department, University Hospital Basel, 4031 Basel, Switzerland
| | - J Kellett
- MD, Department of Emergency Medicine, Hospital of South West Jutland, 6700 Esbjerg, Denmark
| | - M Brabrand
- MD, PhD, Department of Emergency Medicine, Hospital of South West Jutland, 6700 Esbjerg, Denmark
| | - N R Simon
- MD, Emergency Department, University Hospital Basel, 4031 Basel, Switzerland
| | - M Rueegg
- MD, Emergency Department, University Hospital Basel, 4031 Basel, Switzerland
| | - R Twerenbold
- MD, Department of Cardiology, University Hospital Basel, 4031 Basel, Switzerland
| | - S Osswald
- MD, Department of Cardiology, University Hospital Basel, 4031 Basel, Switzerland
| | - S Bassetti
- MD, Department of Internal Medicine, University Hospital Basel, 4031 Basel, Switzerland
| | - S Tschudin-Sutter
- MD, Division of Infectious Disease & Hospital Epidemiology, University Hospital Basel, 4031 Basel, Switzerland
| | - M Siegemund
- MD, Department of Intensive Care, University Hospital Basel, 4031 Basel, Switzerland
| | - K Rentsch
- PhD, Department of Laboratory Medicine, University Hospital Basel, 4031 Basel, Switzerland
| | - R Bingisser
- MD, Emergency Department, University Hospital Basel, 4031 Basel, Switzerland
| | - C H Nickel
- MD, Emergency Department, University Hospital Basel, 4031 Basel, Switzerland
| |
Collapse
|
2
|
Hunziker L, Radovanovic D, Jeger R, Pedrazzini G, Cuculi F, Urban P, Erne P, Rickli H, Pilgrim T, Hess F, Simon R, Hangartner P, Hufschmid U, Hornig B, Altwegg L, Trummler S, Windecker S, Rueff T, Loretan P, Roethlisberger C, Evéquoz D, Mang G, Ryser D, Müller P, Jecker R, Kistler W, Hongler T, Stäuble S, Freiwald G, Schmid H, Stauffer J, Cook S, Bietenhard K, Roffi M, Wojtyna W, Schönenberger R, Simonin C, Waldburger R, Schmidli M, Federspiel B, Weiss E, Marty H, Weber K, Zender H, Poepping I, Hugi A, Koltai E, Iglesias J, Erne P, Heimes T, Jordan B, Pagnamenta A, Feraud P, Beretta E, Stettler C, Repond F, Widmer F, Heimgartner C, Polikar R, Bassetti S, Iselin H, Giger M, Egger P, Kaeslin T, Fischer A, Herren T, Eichhorn P, Neumeier C, Flury G, Girod G, Vogel R, Niggli B, Yoon S, Nossen J, Stoller U, Veragut U, Bächli E, Weber A, Schmidt D, Hellermann J, Eriksson U, Fischer T, Peter M, Gasser S, Fatio R, Vogt M, Ramsay D, Wyss C, Bertel O, Maggiorini M, Eberli F, Christen S. Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry. Circ Cardiovasc Interv 2019; 12:e007293. [DOI: 10.1161/circinterventions.118.007293] [Citation(s) in RCA: 54] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Lukas Hunziker
- Department of Cardiology, Bern University Hospital, Switzerland (L.H., T.P.)
| | - Dragana Radovanovic
- AMIS Plus Data Center, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Switzerland (D.R.)
| | - Raban Jeger
- Division of Cardiology, University Hospital Basel, Switzerland (R.J.)
| | | | - Florim Cuculi
- Heart Centre Lucerne, Luzerner Kantonsspital, Switzerland (F.C.)
| | - Philip Urban
- Cardiology Department, La Tour Hospital, Geneva, Switzerland (P.U.)
| | - Paul Erne
- Department of Biomedicine, University of Basel, Switzerland (P.E.)
| | - Hans Rickli
- Department of Cardiology, Kantonsspital St. Gallen, Switzerland (H.R.)
| | - Thomas Pilgrim
- Department of Cardiology, Bern University Hospital, Switzerland (L.H., T.P.)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Faller N, Stalder O, Limacher A, Bassetti S, Beer JH, Genné D, Battegay E, Hayoz D, Leuppi J, Mueller B, Perrier A, Waeber G, Rodondi N, Aujesky D. Frequency of use and acceptability of clinical prediction rules for pulmonary embolism among Swiss general internal medicine residents. Thromb Res 2017; 160:9-13. [PMID: 29080550 DOI: 10.1016/j.thromres.2017.09.028] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2017] [Revised: 09/25/2017] [Accepted: 09/30/2017] [Indexed: 10/18/2022]
Abstract
INTRODUCTION Whether clinical prediction rules for pulmonary embolism are accepted and used among general internal medicine residents remains uncertain. We therefore evaluated the frequency of use and acceptability of the Revised Geneva Score (RGS) and the Pulmonary Embolism Severity Index (PESI), and explored which factors were associated with rule use. MATERIALS/METHODS In an online survey among general internal medicine residents from 10 Swiss hospitals, we assessed rule acceptability using the Ottawa Acceptability of Decision Rules Instrument (OADRI) and explored the association between physician and training-related factors and rule use using mixed logistic regression models. RESULTS The response rate was 50.4% (433/859). Overall, 61% and 36% of the residents reported that they always or regularly use the RGS and the PESI, respectively. The mean overall OADRI score was 4.3 (scale 0-6) for the RGS and 4.1 for the PESI, indicating a good acceptability. Rule acceptability (odds ratio [OR] 6.19 per point, 95% confidence interval [CI] 3.64-10.51), prior training in emergency medicine (OR 5.14, CI 2.20-12.01), and availability of internal guidelines recommending RGS use (OR 4.25, CI 2.15-8.43) were associated with RGS use. Rule acceptability (OR 6.43 per point, CI 4.17-9.92) and rule taught at medical school (OR 2.06, CI 1.24-3.43) were associated with PESI use. CONCLUSIONS The RGS was more frequently used than the PESI. Both rules were considered acceptable. Rule acceptability, prior training in emergency medicine, availability of internal guidelines, and rule taught at medical school were associated with rule use and represent potential targets for quality improvement interventions.
Collapse
Affiliation(s)
- N Faller
- Department of General Internal Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.
| | - O Stalder
- CTU Bern, and Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland
| | - A Limacher
- CTU Bern, and Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland
| | - S Bassetti
- Division of Internal Medicine, Basel University hospital, Basel, Switzerland
| | - J H Beer
- Department of Internal Medicine, Cantonal Hospital of Baden, Baden, Switzerland
| | - D Genné
- Department of Internal Medicine, Cantonal Hospital of Biel, Biel, Switzerland
| | - E Battegay
- Department of Internal Medicine, Zürich University Hospital, Zürich, Switzerland
| | - D Hayoz
- Department of Internal Medicine, Cantonal Hospital of Fribourg, Fribourg, Switzerland
| | - J Leuppi
- University Clinic of Internal Medicine, Cantonal Hospital Baselland, Liestal, and University of Basel, Switzerland
| | - B Mueller
- Medical University Department, Division of General Internal and Emergency Medicine, Cantonal Hospital of Aarau, Aarau, Switzerland
| | - A Perrier
- Department of Internal Medicine, Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland
| | - G Waeber
- Department of Internal Medicine, Lausanne University Hospital, Lausanne, Switzerland
| | - N Rodondi
- Department of General Internal Medicine, Bern University Hospital, University of Bern, Bern, Switzerland; Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland
| | - D Aujesky
- Department of General Internal Medicine, Bern University Hospital, University of Bern, Bern, Switzerland
| |
Collapse
|
4
|
Piso RJ, Pop R, Wieland M, Griesshammer I, Urfer M, Schibli U, Bassetti S. Low sensitivity of needle aspiration cultures in patients with cellulitis/erysipelas. Springerplus 2016; 5:1578. [PMID: 27652151 PMCID: PMC5025406 DOI: 10.1186/s40064-016-3293-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 09/08/2015] [Accepted: 09/11/2016] [Indexed: 11/24/2022]
Abstract
Purpose Cellulitis is normally treated without knowledge of the responsible pathogen. Blood cultures are positive in about 2–4 %, and superficial swabs are of no value. Needle aspiration has been proposed with identifying the likely pathogen in up to 29 %, but these studies are of older date and the technique is not widely used. Methods We prospectively evaluated the sensitivity of needle aspiration cultures in all patients with erysipelas/cellulitis. Diagnosis was made clinically by the treating physician. Needle aspiration was done with a 1 ml syringe and a 26G needle. The needle was removed and the syringe brought to the microbiological laboratory and analysed according to standard procedures. Results 95 Patients were seen during a period of 22 month. 4 Patients were excluded, as diagnosis was not confirmed. Cellulitis was present in 10/91 and erysipelas in 81/91 patients. In the first 25 patients with needle aspiration from the margin, none was positive. In 8/66 (12 %) patients where needle aspiration was done at the site of maximum inflammation, the pathogen was identified. 4/8 Cultures were positive for S. aureus, 2/8 for streptococci and 2/8 for other bacteria. In 11/66 (16.6 %) patients, skin colonisation flora was detected. In the subgroup of patients without prior antibiotic treatment and needle aspiration from the site of maximum inflammation, sensitivity was slightly better 8/55 (14.5 %; 95 % CI 7.5–25.8 %). Conclusions Needle aspiration culture had a low sensitivity for detecting responsible pathogen in patients with cellulitis/erysipelas. No impact in antibiotic treatment could be observed.
Collapse
Affiliation(s)
- Rein Jan Piso
- Medizinische Klinik, Kantonsspital, Baslerstrasse 150, 4600 Olten, CH Switzerland
| | - R Pop
- Medizinische Klinik, Kantonsspital, Baslerstrasse 150, 4600 Olten, CH Switzerland
| | - M Wieland
- Medizinische Klinik, Kantonsspital, Baslerstrasse 150, 4600 Olten, CH Switzerland
| | - I Griesshammer
- Medizinische Klinik, Kantonsspital, Baslerstrasse 150, 4600 Olten, CH Switzerland
| | - M Urfer
- Medizinische Klinik, Kantonsspital, Baslerstrasse 150, 4600 Olten, CH Switzerland
| | - U Schibli
- Bakteriologisches Institut Olten, Kantonsspital, Olten, Switzerland
| | - S Bassetti
- Division of Internal Medicine, University Hospital Basel, Basel, Switzerland
| |
Collapse
|
5
|
Osthoff M, Gürtler N, Bassetti S, Balestra G, Marsch S, Pargger H, Weisser M, Egli A. Impact of MALDI-TOF-MS-based identification directly from positive blood cultures on patient management: a controlled clinical trial. Clin Microbiol Infect 2016; 23:78-85. [PMID: 27569710 DOI: 10.1016/j.cmi.2016.08.009] [Citation(s) in RCA: 53] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2016] [Revised: 08/17/2016] [Accepted: 08/18/2016] [Indexed: 01/30/2023]
Abstract
OBJECTIVES Rapid identification of pathogens directly from positive blood cultures (BC) in combination with an antimicrobial stewardship programme (ASP) is associated with improved antibiotic treatment and outcomes, but the effect of each individual intervention is less clear. The current study investigated the impact of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) versus conventional identification on antibiotic management in a setting with a well-established ASP and low resistance rates. METHODS In this single-centre open label, controlled clinical trial 425 patients with positive BCs were allocated by weekday during a 1-year period to either MALDI-TOF directly from positive BCs or conventional processing. ASP was identical throughout the study period. The primary outcome was duration of intravenous antimicrobial therapy and was analysed in an intention-to-treat approach. RESULTS In all, 368 patients were analysed (MALDI-TOF n = 168; conventional n = 200) with similar baseline characteristics. Mean duration of intravenous antimicrobial therapy (12.9 versus 13.2 days, p 0.9) and length of stay (16.1 versus 17.9 days, p 0.3) were comparable. In the clinically significant bloodstream infection subgroup (n = 242) mean time from Gram-stain to active treatment was significantly shorter (3.7 versus 6.7 h, p 0.003). Admission to the intensive care unit after bloodstream infection onset was less frequent in the MALDI-TOF group (23.1 versus 37.2%, p 0.02). CONCLUSIONS Rapid identification of contaminated BCs (n = 126) resulted in a shorter duration of intravenous antimicrobial therapy (mean 4.8 versus 7.5 days, p 0.04). Rapid identification using MALDI-TOF directly from positive BCs did not impact on duration of intravenous antimicrobial therapy, but provided fast and reliable microbiological results and may improve treatment quality in the setting of an established ASP.
Collapse
Affiliation(s)
- M Osthoff
- Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
| | - N Gürtler
- Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
| | - S Bassetti
- Department of Internal Medicine, University Hospital Basel, Basel, Switzerland
| | - G Balestra
- Medical Intensive Care Unit, University Hospital Basel, Basel, Switzerland
| | - S Marsch
- Medical Intensive Care Unit, University Hospital Basel, Basel, Switzerland
| | - H Pargger
- Surgical Intensive Care Unit, University Hospital Basel, Basel, Switzerland
| | - M Weisser
- Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
| | - A Egli
- Division of Clinical Microbiology, University Hospital Basel, Basel, Switzerland; Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
| |
Collapse
|
6
|
Dusemund F, Bucher B, Meyer S, Thomann R, Kühn F, Bassetti S, Sprenger M, Baechli E, Sigrist T, Schwietert M, Amin D, Hausfater P, Carre E, Schuetz P, Gaillat J, Regez K, Bossart R, Schild U, Müller B, Albrich WC. Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance. Eur J Clin Microbiol Infect Dis 2012; 32:51-60. [PMID: 22886090 DOI: 10.1007/s10096-012-1713-8] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2012] [Accepted: 07/23/2012] [Indexed: 01/27/2023]
Abstract
Procalcitonin (PCT)-guided antibiotic stewardship is a successful strategy to decrease antibiotic use. We assessed if clinical judgement affected compliance with a PCT-algorithm for antibiotic prescribing in a multicenter surveillance of patients with lower respiratory tract infections (LRTI). Initiation and duration of antibiotic therapy, adherence to a PCT algorithm and outcome were monitored in consecutive adults with LRTI who were enrolled in a prospective observational quality control. We correlated initial clinical judgment of the treating physician with algorithm compliance and assessed the influence of PCT on the final decision to initiate antibiotic therapy. PCT levels correlated with physicians' estimates of the likelihood of bacterial infection (p for trend <0.02). PCT influenced the post-test probability of antibiotic initiation with a greater effect in patients with non-pneumonia LRTI (e.g., for bronchitis: -23 % if PCT ≤ 0.25 μg/L and +31 % if PCT > 0.25 μg/L), in European centers (e.g., in France -22 % if PCT ≤ 0.25 μg/L and +13 % if PCT > 0.25 μg/L) and in centers, which had previous experience with the PCT-algorithm (-16 % if PCT ≤ 0.25 μg/L and +19 % if PCT > 0.25 μg/L). Algorithm non-compliance, i.e. antibiotic prescribing despite low PCT-levels, was independently predicted by the likelihood of a bacterial infection as judged by the treating physician. Compliance was significantly associated with identification of a bacterial etiology (p = 0.01). Compliance with PCT-guided antibiotic stewardship was affected by geographically and culturally-influenced subjective clinical judgment. Initiation of antibiotic therapy was altered by PCT levels. Differential compliance with antibiotic stewardship efforts contributes to geographical differences in antibiotic prescribing habits and potentially influences antibiotic resistance rates.
Collapse
Affiliation(s)
- F Dusemund
- Medical University Department, Kantonsspital Aarau, Tellstrasse, CH-5001 Aarau, Switzerland
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Abstract
Skin- and Soft tissue infections are a frequent problem in hospital as well as in ambulatory care. Diagnostic procedures and treatment principles have to include the most frequent pathogens. While the acute forms of skin and soft tissue infections, with, necrotising fasciitis as important exception, rarely cause diagnostic or therapeutic problem, the treatment of patients with recurrent furunculosis, chronic wounds and diabetic feet is often difficult and frustration for patients and physicians. This article gives an overview of the most important problems and treatment strategies.
Collapse
Affiliation(s)
- R J Piso
- Medizinische Klinik, Kantonsspital Olten.
| | | |
Collapse
|
8
|
Tièche R, Piso RJ, Bassetti S. [Transmission of Influenza A]. Praxis (Bern 1994) 2011; 100:417-422. [PMID: 21452128 DOI: 10.1024/1661-8157/a000483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
The pandemic influenza A 2009 virus led to new discussions about proper protection measures in hospitals and in the general population. To implement efficacious protection measures against the influenza A virus, we have to know its way of transmission. Influenza A transmission occurs primarily via droplets and contact. However, several experimental studies and observations of outbreaks indicate that influenza can also be transmitted through the airborne route (via aerosols). The possibility of airborne transmission of influenza should be taken in consideration for pandemic influenza planning and recommendations. In case of influenza epidemics with high (or not yet defined) mortality, exposed healthcare personnel should be protected using precautions against airborne transmission, including the use of FFP2 (N95) respirators.
Collapse
Affiliation(s)
- R Tièche
- Medizinische Klinik, Kantonsspital Olten
| | | | | |
Collapse
|
9
|
Piso RJ, Albrecht Y, Handschin P, Bassetti S. Low transmission rate of 2009 H1N1 Influenza during a long-distance bus trip. Infection 2011; 39:149-53. [PMID: 21340580 PMCID: PMC7099280 DOI: 10.1007/s15010-011-0084-x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2010] [Accepted: 01/20/2011] [Indexed: 11/27/2022]
Abstract
Background Current data on the risk of transmission of 2009 H1N1 Influenza in public transportation systems (e.g., public trains, busses, airplanes) are conflicting. The main transmission route of this virus is thought to be via droplets, but airborne transmission has not been completely ruled out. Methods This is a contact tracing investigation of a young woman subsequently diagnosed with the 2009 H1N1 Influenza virus who was symptomatic during a long-distance bus trip from Spain to Switzerland. Fever and cough had begun 24 h earlier, 2 h before she stepped onto a bus for a long-distance trip. After the 2009 H1N1 virus had been confirmed in the patient, the other bus travellers were contacted by telephone on day 7 and 10 after the bus trip. Results Of the 72 individuals travelling on the bus with the H1N1-infected young woman, 52 (72%) could be contacted. Only one of these 52 developed fever, with onset of symptoms 3 days after the bus trip, and rRT-PCR analysis of the nasopharyngeal swab showed the infection to be caused by the 2009 H1N1 virus. One other person complained of coughing 1 day after the bus trip, but without fever, and no further investigation was carried out. All other passengers remained without fever, coughing, or arthralgia. The risk of transmission was calculated as 1.96% (95% confidence interval 0–5.76%). Conclusion The transmission rate of 2009 H1N1 Influenza was low on a long-distance bus trip. Electronic supplementary material The online version of this article (doi:10.1007/s15010-011-0084-x) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- R J Piso
- Medizinische Klinik, Kantonsspital, 4500, Olten, Switzerland.
| | | | | | | |
Collapse
|
10
|
Widmer A, Hohl P, Dirnhofer S, Bassetti S, Marsch S, Frei R. Legionella bozemanii, an elusive agent of fatal cavitary pneumonia. Infection 2007; 35:180-1. [PMID: 17565460 DOI: 10.1007/s15010-007-6251-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2006] [Accepted: 02/26/2007] [Indexed: 10/23/2022]
Abstract
A 67-year-old patient died of Legionella bozemanii pneumonia with negative urinary antigen and negative serology. Cystic lesions in pneumonia of unknown origin should lead to the differential diagnosis of L. bozemanii infections.
Collapse
Affiliation(s)
- A Widmer
- Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, 4031 Basel, Switzerland.
| | | | | | | | | | | |
Collapse
|
11
|
Haller P, Bruderer T, Schaeren S, Laifer G, Frei R, Battegay M, Flückiger U, Bassetti S. Vertebral osteomyelitis caused by Actinobaculum schaalii: a difficult-to-diagnose and potentially invasive uropathogen. Eur J Clin Microbiol Infect Dis 2007; 26:667-70. [PMID: 17618471 DOI: 10.1007/s10096-007-0345-x] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
We report the first case of vertebral osteomyelitis caused by Actinobaculum schaalii and review all cases of A. schaalii identified at our institution between 2002 and 2005. A. schaalii causes urinary tract infections - especially in elderly people - occasionally with septic complications.
Collapse
Affiliation(s)
- P Haller
- Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Switzerland
| | | | | | | | | | | | | | | |
Collapse
|
12
|
Weisser M, Khanlari B, Terracciano L, Arber C, Gratwohl A, Bassetti S, Hatz C, Battegay M, Flückiger U. Visceral leishmaniasis: a threat to immunocompromised patients in non-endemic areas? Clin Microbiol Infect 2007; 13:751-3. [PMID: 17610597 DOI: 10.1111/j.1469-0691.2007.01755.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Visceral leishmaniasis is rare in western Europe, but may be life-threatening in immunocompromised patients. It is therefore important to understand the incidence of the disease in a non-endemic area and its relationship with immunosuppressive conditions. Between 1990 and 2005, 12 patients were diagnosed with leishmaniasis at Basel University Hospital, Switzerland. Eleven presented with visceral symptoms and ten had an underlying immunosuppressive condition. Since increasing numbers of immunosuppressed patients have a history of travel to endemic countries, an association of visceral leishmaniasis with cellular immunosuppression (other than that associated with human immunodeficiency virus) might become more frequent in non-endemic areas.
Collapse
Affiliation(s)
- M Weisser
- Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
| | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Laifer G, Bassetti S. [Diagnostics for pulmonary tuberculosis in adults]. Internist (Berl) 2007; 48:489-90, 492-4, 496. [PMID: 17333051 DOI: 10.1007/s00108-007-1814-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
The incidence of pulmonary tuberculosis (TB) is decreasing in Western Europe. However, TB should not be considered to be a rare disease, particularly in immigrants and in immunocompromised persons (i.e. HIV infection). The clinical presentation is often atypical in immunocompromised persons. In general, the extent of the disease is underestimated by the clinical presentation. X-ray and a sequential investigation of three samples of sputum including microscopy, culture and susceptibility testing for the first-line drugs should be obtained. Tuberculin testing is useful in the diagnosis of latent TB and in screening persons with close contact to patients with active disease. New blood tests based on the detection of interferon-g released by antigen specific T-cells have some advantages compared to tuberculin testing.
Collapse
Affiliation(s)
- G Laifer
- Klinik für Infektiologie, Universitätsspital Basel, Petersgraben 4, CH-4031 Basel.
| | | |
Collapse
|
14
|
Thierfelder C, Landolt M, Bassetti S. [36-year-old patient with myalgia and pain-associated insomnia]. Praxis (Bern 1994) 2006; 95:1505-7. [PMID: 17061465 DOI: 10.1024/1661-8157.95.39.1505] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Abstract
Bei einem 38-jährigen Patienten war eine akut aufgetretene Polyneuropathie wegweisend für die Diagnose einer HIV-Primoinfektion. 10–20% der HIV-Infizierten zeigen als erstes Symptom eine neurologische Symptomatik. Die akute HIV-Infektion wird aufgrund einer Vielzahl unspezifischer Symptome häufig verpasst. Falls Verdacht darauf besteht, muss ein kombinierter Suchtest zum Nachweis von HIV-Antikörpern und vom p24-Antigen durchgeführt werden. Wegen des hohen Transmissionsrisikos bei hoher Viruslast im Frühstadium ist die frühzeitige Diagnosestellung von Bedeutung. Die Frühtherapie einer HIV-Infektion ist aufgrund fehlender prospektiv vergleichender Studien kontrovers.
Collapse
|
15
|
Abstract
Diagnosis of all types of cutaneous tuberculosis is challenging because the clinical picture of these diseases is highly variable. We describe the case of a 79-year old woman with an atypical presentation of Erythema induratum Bazin (EIB) on the chest and left arm in association with a tuberculous osteomyelitis of the left olecranon. Surprisingly, M. tuberculosis grew also from biopsies of the EIB-lesions. This contradicts the conventional view that considers EIB (a tuberculid) to be caused by a hypersensitivity reaction to mycobacteria. The presented case supports the hypothesis that EIB may also be caused by hematogenous or lymphatic spread of viable M. tuberculosis.
Collapse
Affiliation(s)
- M Degonda Halter
- Klinik für Infektiologie und Spitalhygiene, Universitätsspital, 4031, Basel.
| | | | | | | | | | | |
Collapse
|
16
|
Kaech C, Elzi L, Sendi P, Frei R, Laifer G, Bassetti S, Fluckiger U. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Clin Microbiol Infect 2006; 12:345-52. [PMID: 16524411 DOI: 10.1111/j.1469-0691.2005.01359.x] [Citation(s) in RCA: 119] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Staphylococcus aureus bacteraemia (SAB) is associated with substantial morbidity and mortality worldwide. The charts of adult patients with SAB who were hospitalised in a Swiss tertiary-care centre between 1998 and 2002 were studied retrospectively. In total, 308 episodes of SAB were included: 2% were caused by methicillin-resistant strains; 49% were community-acquired; and 51% were nosocomial. Bacteraemia without focus was the most common type of community-acquired SAB (52%), whereas intravenous catheter-related infection predominated (61%) among nosocomial episodes of SAB. An infectious diseases (ID) specialist was consulted in 82% of all cases; 83% received appropriate antibiotic treatment within 24 h of obtaining blood cultures. Overall hospital-associated mortality was 20%. Community-acquired SAB was associated independently with a higher mortality rate than nosocomial SAB (26% vs. 13%; p 0.009). Independent risk-factors for a fatal outcome were age (p < 0.001), immunosuppression (p 0.007), alcoholism (p < 0.001), haemodialysis (p 0.03), acute renal failure (p < 0.001) and septic shock (p < 0.001). Consultation with an ID specialist was associated with a better outcome in univariate analysis (p < 0.001). Compared with a previous retrospective analysis performed at the same institution between 1980 and 1986, there was a 140% increase in community-acquired SAB, a 60% increase in catheter-related SAB, and a 14% reduction in mortality. In conclusion, mortality in patients with SAB remained high, despite effective antibiotic therapy. Patients with community-acquired SAB were twice as likely to die as patients with nosocomial SAB. Consultation with an ID specialist may reduce mortality in patients with SAB.
Collapse
Affiliation(s)
- C Kaech
- Department of Internal Medicine, University Hospital Basel, Basel, Switzerland
| | | | | | | | | | | | | |
Collapse
|
17
|
Pfefferkorn U, Viehl CT, Bassetti S, Wolff T, Oertli D. [Injection site abscesses in intravenous drug users. Frequency of associated complications related to localisation]. Chirurg 2006; 76:1053-7. [PMID: 15971034 DOI: 10.1007/s00104-005-1042-x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
BACKGROUND Skin and soft tissue infections are the most frequent cause of hospital admissions among intravenous drug users. Associated complications include septic arthritis, septic thrombosis and embolisation, peripheral ischaemia due to intra-arterial injections, venous and arterial pseudoaneurysms, local destruction of adjacent structures, and necrotising fasciitis. METHODS We conducted a retrospective review of the associated complications of 85 patients with 130 abscesses treated during 108 hospital stays. RESULTS The majority of abscesses (55%) were located on the lower extremities, where the complication rate following injections was significantly higher than in other parts of the body (12/71 vs 0/55, P=0.0005). Patients with abscesses on the lower extremities had significantly longer hospital stay than those with abscesses on other localisations (8.5 days vs 4.2 days, P=0.0005) and therefore were more expensive to treat. CONCLUSIONS Surgeons treating abscesses caused by intravenous drug use must be aware of the higher rate of associated complications after injection in the lower extremities. Prevention in drug addiction programs could reduce complications and costs related to drug use by avoiding injection sites on the lower extremities.
Collapse
Affiliation(s)
- U Pfefferkorn
- Departement Chirurgie, Universitätsspital Basel, Schweiz.
| | | | | | | | | |
Collapse
|
18
|
Evison J, Aebi C, Francioli P, Péter O, Bassetti S, Gervaix A, Zimmerli S, Weber R. [Lyme disease Part I: epidemiology and diagnosis]. Rev Med Suisse 2006; 2:919-24. [PMID: 16673723] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/09/2023]
Affiliation(s)
- J Evison
- Poliklinik und Klinik für Infektionskrankheiten Medizinische Universitätskinderklinik Inselspital, 3010 Bern.
| | | | | | | | | | | | | | | |
Collapse
|
19
|
Evison J, Aebi C, Francioli P, Péter O, Bassetti S, Gervaix A, Zimmerli S, Weber R. [Lyme disease Part 3: prevention, pregnancy, immunodeficient state, post-Lyme disease syndrome]. Rev Med Suisse 2006; 2:935-6, 938-40. [PMID: 16673725] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/09/2023]
Affiliation(s)
- J Evison
- Poliklinik und Klinik für Infektionskrankheiten Medizinische Universitätskinderklinik, Inselspital, 3010 Bern
| | | | | | | | | | | | | | | |
Collapse
|
20
|
Evison J, Aebi C, Francioli P, Péter O, Bassetti S, Gervaix A, Zimmerli S, Weber R. [Lyme disease Part 2: clinic and treatment]. Rev Med Suisse 2006; 2:925-8, 930-4. [PMID: 16673724] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/09/2023]
Affiliation(s)
- J Evison
- Poliklinik und Klinik für Infektionskrankheiten Medizinische Universitätskinderklinik Inselspital, 3010 Bern
| | | | | | | | | | | | | | | |
Collapse
|
21
|
Bassetti S. Therapie und Prävention der Lyme-Borreliose. Therapeutische Umschau 2005; 62:751-5. [PMID: 16350538 DOI: 10.1024/0040-5930.62.11.751] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Die verschiedenen Stadien der Lyme-Borreliose können wirksam antibiotisch behandelt werden. In der Regel müssen nur Lyme-Borreliosen mit einer ZNS-Beteiligung oder Lyme-Karditis und AV-Block III. Grades parenteral behandelt werden, während alle anderen Formen der Lyme-Borreliose per os behandelt werden können. In den letzten Jahren kann eine Tendenz zur Verlängerung der Therapien festgestellt werden. Allerdings existieren keine Studien, welche einen Vorteil von längeren Therapien zeigen. Das Risiko einer Lyme-Borreliose nach einem Zeckenstich in der Schweiz ist gering. Eine Antibiotika-Prophylaxe nach Zeckenstich wird nicht empfohlen.
Collapse
Affiliation(s)
- S Bassetti
- Klinik für Infektiologie, Universitätsspital Basel, Basel.
| |
Collapse
|
22
|
Abstract
African tick bite fever (ATBF) is an infectious disease commonly observed in travelers to sub-Saharan Africa. Because the presentation of the disease is often not specific, ATBF is frequently not diagnosed or confused with Mediterranean spotted fever. We present the case of a 63-year-old woman with typical history and symptoms. The diagnosis of ATBF was serologically confirmed by immunofluoroscence. ATBF is an important differential diagnosis of fever in patients returning from sub-Saharan Africa.
Collapse
Affiliation(s)
- C Strub
- Dermatologische Universitätspoliklinik, Universitätsspital Basel, Schweiz
| | | | | |
Collapse
|
23
|
Abstract
Rickettsioses are among the most frequent causes of febrile diseases in travelers, as shown in several studies in the last years. Furthermore, since 1991, with the introduction of new testing methods, 8 new Rickettsia species (or new diseases) have been described. Typical symptoms of rickettsial infections are high fever, headaches and myalgias, frequently associated with a rash and/or an inoculation eschar ("tache noire") at the site of tick bite. The rapid recognition of a rickettsiosis and the immediate start of appropriate antibiotic therapy are important because some rickettsioses (e. g. the Rocky Mountain spotted fever) are associated with relevant morbidity and mortality. This paper reviews the spotted fever group rickettsioses.
Collapse
Affiliation(s)
- S Bassetti
- Klinik für Infektiologie, Universitätskliniken Basel, Switzerland.
| |
Collapse
|
24
|
Bassetti S, Battegay M. Staphylococcus aureus Infections in Injection Drug Users: Risk Factors and Prevention Strategies. Infection 2004; 32:163-9. [PMID: 15188077 DOI: 10.1007/s15010-004-3106-0] [Citation(s) in RCA: 75] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2003] [Accepted: 12/16/2003] [Indexed: 11/25/2022]
Abstract
Infections, in particular soft tissue infections (cellulitis, skin abscesses), are the leading cause for emergency department visits and hospital admissions of drug injection users (IDUs). Staphylococcus aureus is the most relevant bacterial pathogen in this population. It is the main cause of soft tissue infections and of severe infections such as endocarditis and bacteremia. Moreover, epidemic spread of methicillin-resistant S. aureus (MRSA) among IDUs has occurred in Europe and North America. Nasal carriage of S. aureus is associated with an increased risk of subsequent S. aureus infections, and it has been shown that active IDUs have a higher rate of colonization with S. aureus than the general population. However, it is still unknown why an individual carries S. aureus. In particular, repeated injections do not appear to be the main predisposing factor for S. aureus carriage. Infections associated with injection drug use are frequently the consequence of the illegal status of street drugs. Harm reduction programs, including needle exchange programs, safer injecting facilities and injection opiate substitution programs can reduce the incidence of infections among severely addicted IDUs.
Collapse
Affiliation(s)
- S Bassetti
- Division of Infectious Diseases, University Hospital Basel, CH-4031 Basel, Switzerland.
| | | |
Collapse
|
25
|
Bassetti S. ["Antibiotic stewardship": catchword or necessity?]. Praxis (Bern 1994) 2004; 93:623-625. [PMID: 15108851 DOI: 10.1024/0369-8394.93.15.623] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
Als «antibiotic stewardship» bezeichnet man Strategien oder Massnahmen zur Optimierung des Antibiotika-Einsatzes. «Antibiotic stewardship» Programme sind ein wichtiger Bestandteil der Prävention von Antibiotika-Resistenzen. Von «antibiotic stewardship»-Programmen ist nicht nur ein Nutzen auf gesellschsaftlicher Ebene zu erwarten (weniger Antibiotika-Resistenzen), sondern auch auf individueller Ebene: jeder einzelne Patient profitiert von der korrekten Anwendung der Antibiotika (Einsatz der Substanz mit der besten Wirkung gegen den jeweiligen Krankheitserreger, korrekte Dauer der Therapie usw.). Zusätzlich können «antibiotic stewardship»-Programme einen Beitrag zur Kontrolle der Medikamenten-Ausgaben leisten.
Collapse
Affiliation(s)
- S Bassetti
- Abteilung für Infektiologie, Bereich Innere Medizin, Kantonsspital Basel.
| |
Collapse
|
26
|
Bassetti S, Dunagan DP, D'Agostino RB, Sherertz RJ. Nasal carriage of Staphylococcus aureus among patients receiving allergen-injection immunotherapy: associated factors and quantitative nasal cultures. Infect Control Hosp Epidemiol 2001; 22:741-5. [PMID: 11876451 DOI: 10.1086/501857] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
OBJECTIVE To compare the prevalence of nasal Staphylococcus aureus carriage among outpatients receiving allergen-injection immunotherapy with the prevalence among healthy controls and to determine predictors of nasal S. aureus carriage. DESIGN Survey. SETTING Allergy clinic of a university hospital. PARTICIPANTS A volunteer sample consisting of 45 outpatients undergoing desensitization therapy and 84 first- and second-year medical students. RESULTS The nasal S. aureus carriage rate was significantly higher among patients (46.7%) than among students (26.2%; P=.019). In a multivariate model adjusted for age and gender, the presence of atopic dermatitis or eczema was the only independent predictor of nasal S. aureus carriage (odds ratio [OR], 4.4; 95% confidence interval [CI95], 1.2-16.0; P=.02). The only other participant characteristic associated with nasal S. aureus carriage was immunotherapy with allergen injections (OR, 1.98; CI95, 0.7-6.0), but this association did not reach statistical significance (P=.23). The probability of nasal S. aureus carriage was 88.9% for patients receiving allergen injections and having atopic dermatitis or eczema, and 36.1% for patients receiving allergen injections without atopic dermatitis or eczema. CONCLUSIONS Patients undergoing desensitization have a higher nasal carriage rate of S. aureus. However, factors other than the regular use of needles, and in particular abnormalities related to the atopic constitution of these patients, may predispose this population for S. aureus carriage.
Collapse
Affiliation(s)
- S Bassetti
- Section on Infectious Diseases, Wake Forest University School of Medicine, Winston-Salem, North-Carolina 27157-1042, USA
| | | | | | | |
Collapse
|
27
|
Bassetti S, Hu J, D'Agostino RB, Sherertz RJ. Prolonged antimicrobial activity of a catheter containing chlorhexidine-silver sulfadiazine extends protection against catheter infections in vivo. Antimicrob Agents Chemother 2001; 45:1535-8. [PMID: 11302823 PMCID: PMC90501 DOI: 10.1128/aac.45.5.1535-1538.2001] [Citation(s) in RCA: 58] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2000] [Accepted: 02/13/2001] [Indexed: 11/20/2022] Open
Abstract
The present study evaluated in vitro and in vivo a new chlorhexidine (C)-silver sulfadiazine (S) vascular catheter (the CS2 catheter) characterized by a higher C content and by the extended release of the surface-bound antimicrobials. The CS2 catheter was compared with a first-generation, commercially available CS catheter (the CS1 catheter). The CS2 catheter produced slightly smaller zones of inhibition (mean difference, 0.9 mm [P < 0.001]) at 24 h against Staphylococcus aureus and five other microorganisms by several different methodologies. However, in a rabbit model, both CS catheters were similarly efficacious in preventing a catheter infection when the rabbits were inoculated with 10(4) to 10(7) CFU of S. aureus at the time of catheter insertion. The CS2 catheter retained its antimicrobial activity significantly longer in vitro and in vivo (half-lives exceeded 34 and 7 days, respectively) and was also significantly more efficacious in preventing a catheter infection when 10(6) CFU of S. aureus was inoculated 2 days after catheter implantation (P < 0.001). These results suggest that prolonged anti-infective activity on the external catheter surface provides improved efficacy in the prevention of infection.
Collapse
Affiliation(s)
- S Bassetti
- Section on Infectious Diseases, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA
| | | | | | | |
Collapse
|
28
|
Abstract
Certain bacteria dispersed by health-care workers can cause hospital infections. Asymptomatic health-care workers colonized rectally, vaginally, or on the skin with group A streptococci have caused outbreaks of surgical site infection by airborne dispersal. Outbreaks have been associated with skin colonization or viral upper respiratory tract infection in a phenomenon of airborne dispersal of Staphylococcus aureus called the "cloud" phenomenon. This review summarizes the data supporting the existence of cloud health-care workers.
Collapse
Affiliation(s)
- R J Sherertz
- Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1042, USA.
| | | | | |
Collapse
|
29
|
Bassetti S, Hu J, D'Agostino RB, Sherertz RJ. In vitro zones of inhibition of coated vascular catheters predict efficacy in preventing catheter infection with Staphylococcus aureus in vivo. Eur J Clin Microbiol Infect Dis 2000; 19:612-7. [PMID: 11014624 DOI: 10.1007/s100960000330] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
This report summarizes data from 35 rabbit model experiments investigating the relationship between in vitro anti-infective catheter coating zones of inhibition and in vivo efficacy. The rabbit model studies involving 15 anti-infective coatings demonstrate an inverse correlation between the sizes of zones of inhibition of Staphylococcus aureus and both the quantity of Staphylococcus aureus removed from the catheter and the risk of a purulent infection. The review of seven previously published clinical trials reveals that the use of anti-infective coated catheters, efficacious in the rabbit model, was associated with a higher success rate than the use of uncoated catheters in preventing both Staphylococcus aureus catheter colonization (odds ratio: 1.28; 95% confidence interval: 0.84-1.93) and Staphylococcus aureus catheter-related bloodstream infection (odds ratio: 3.07; 95% confidence interval: 0.98-9.60) in humans. These findings strongly suggest a correlation between zones of inhibition and in vivo efficacy. In vitro zones of inhibition may serve as a useful screening test for evaluating new anti-infective coatings.
Collapse
Affiliation(s)
- S Bassetti
- Section on Infectious Diseases, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1042, USA
| | | | | | | |
Collapse
|
30
|
|
31
|
Opravil M, Cone RW, Fischer M, Vernazza PL, Bassetti S, Lorenzi P, Bisset LR, Ott P, Huber W, Knuchel MC, Roos M, Lüthy R, Weber R. Effects of early antiretroviral treatment on HIV-1 RNA in blood and lymphoid tissue: a randomized trial of double versus triple therapy. Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 2000; 23:17-25. [PMID: 10708052 DOI: 10.1097/00126334-200001010-00003] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
To assess the effects of early initiation of antiretroviral therapy on cell-free and cell-associated viral load in blood and lymphoid tissue, we performed a randomized, open-label, multicenter trial comparing a double (zidovudine + lamivudine) and triple (zidovudine + lamivudine + ritonavir) drug combination in treatment-naive, asymptomatic patients with CD4 counts >400 cells/microl. HIV-1 RNA was measured in plasma, peripheral blood mononuclear cells, and sequential tonsil or lymph node biopsies (27 patients); the study follow-up was 2 years. Among 42 randomized patients, the proportion with plasma HIV-1 RNA <50 copies/ml was 16% and 74% at week 24 (p<.001) in those randomized to double and triple therapy, respectively, necessitating frequent treatment intensification in the double arm. After a rapid decline within 4 weeks in both arms, cell-associated HIV-1 RNA decreased further only in those patients with sustained suppression of plasma viral load, but remained almost always detectable at low levels, indicating persisting transcription of viral RNA. CD4 counts increased by 200 to 250 cells/microl at week 96 in both arms without significant differences (intent-to-treat analyses). Thus, even if treatment is initiated early in asymptomatic patients with preserved CD4 counts, three drugs are necessary to achieve sustained decreases of HIV load in blood and lymphoid tissue.
Collapse
Affiliation(s)
- M Opravil
- Division of Infectious Diseases and Hospital Epidemiology, University Hospital, Zurich, Switzerland.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Berneis K, Battegay M, Bassetti S, Nuesch R, Leisibach A, Bilz S, Keller U. Nutritional supplements combined with dietary counselling diminish whole body protein catabolism in HIV-infected patients. Eur J Clin Invest 2000; 30:87-94. [PMID: 10620007 DOI: 10.1046/j.1365-2362.2000.00591.x] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
BACKGROUND Weight loss and protein malnutrition are frequent complications in HIV-infected patients. The effect of an oral nutritional supplement combined with nutritional counselling on whole body protein metabolism was assessed. MATERIALS AND METHODS HIV-infected individuals with a body mass index < 21 kg m-2 or CD4-T cells < 500 micro L-1 in stable clinical condition were randomly allocated to [1] receive either oral nutritional supplements (containing 2510 kJ, complete macro- and micronutrients) and dietary counselling (n = 8), or [2] identical monitoring but no supplements or specific nutritional advice (controls, n = 7). Whole body leucine kinetics and leucine oxidation rate were determined by [1-13C]-leucine infusions and lean and fat mass were measured before and 12 weeks after intervention. RESULTS Leucine oxidation (protein catabolism) decreased in the group receiving nutritional intervention from 0.33 +/- 0.02 to 0.26 +/- 0.02 micromol kg-1 min-1 after 12 weeks (P < 0.05; P < 0.05 vs. control group) but remained unchanged in the control group. Whole body leucine flux showed a tendency to decrease in the intervention group from 1.92 +/- 0.19 to 1.73 +/- 0.14 micromol kg-1 min-1 (P = 0.07) and remained unchanged in the control group (2.21 +/- 0.16 and 2.27 +/- 0.14 micromol kg-1 min-1, respectively). Lean body mass determined by bioelectrical impedance analysis increased in the nutritional intervention group from 84 +/- 2 to 86 +/- 2 per cent (P < 0.05) and fat mass decreased from 17 +/- 2 to 14 +/- 2 per cent (P < 0.05) of total body weight whereas neither mass changed in the control group. Nutritional intervention had no significant effect on lymphocyte CD4 counts, on plasma TNFR 55, TNFR 75 and ILR 2 concentrations and on quality of life. CONCLUSIONS The data demonstrate an anticatabolic effect of nutritional supplements combined with dietary counselling in HIV-infected subjects. They suggest that diminished whole body protein catabolism resulted in a change of body composition (increased lean mass, decreased fat mass).
Collapse
Affiliation(s)
- K Berneis
- University Hospital Basel, Switzerland
| | | | | | | | | | | | | |
Collapse
|
33
|
Sudre P, Pfyffer GE, Bodmer T, Prod'hom G, Furrer H, Bassetti S, Bernasconi E, Matter L, Telenti A, Strässle A, Jacques JP, Weber R. Molecular epidemiology of tuberculosis among HIV-infected persons in Switzerland: a countrywide 9-year cohort study. Swiss HIV Cohort Study. Infection 1999; 27:323-30. [PMID: 10624591 DOI: 10.1007/s150100050037] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
We investigated tuberculosis transmission during a nine-year period (1988-1996) in a countrywide community-based cohort of HIV-infected persons in Switzerland (the Swiss HIV Cohort Study [SHCS]). We estimated the proportion of tuberculosis cases due to reinfection and relapse, and assessed factors which may increase the risk of tuberculosis transmission. HIV-infected persons were followed prospectively and molecular fingerprinting with insertion sequence (IS) 6110, 36-bp direct repeat, and IS6110-PCR was used to determine M. tuberculosis case clustering. Out of 7999 SHCS participants, 267 persons developed tuberculosis. 158 M. tuberculosis isolates from 138 patients were available for study. Molecular analysis identified 33 (24%) episodes of tuberculosis associated with 12 clusters including 2 to 8 patients. Two patients experienced reinfection, and nine had a relapse. Detailed contact investigation identified definite or possible epidemiological links between 21 of 33 cluster patients (64%). Multivariate logistic regression analysis did not identify any risk marker significantly associated with clustering. During a nine-year period, one fourth of tuberculosis cases were grouped in clusters within a selection of 138 HIV-infected patients. This may represent the lowest estimation of recently acquired tuberculosis infection. There were no large institutional or community outbreaks among HIV-infected participants of the Swiss HIV Cohort Study.
Collapse
Affiliation(s)
- P Sudre
- University Hospital, Geneva.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Naef MR, Bucher HC, Erb P, Gyr N, Bassetti S, Battegay M. Reduced infections with HIV and hepatitis A during a Swiss intravenous opiate maintenance program. J Acquir Immune Defic Syndr 1999; 21:349-51. [PMID: 10428117 DOI: 10.1097/00126334-199908010-00016] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
35
|
Bassetti S, Battegay M, Furrer H, Rickenbach M, Flepp M, Kaiser L, Telenti A, Vernazza PL, Bernasconi E, Sudre P. Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 1999; 21:114-9. [PMID: 10360802] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
Abstract
In this cross-sectional survey conducted at the end of 1997 among the physicians of participants of the Swiss HIV Cohort Study (SHCS), 1487 of 2154 patients (69.0%) were treated with highly active antiretroviral treatment (HAART) defined as triple therapy with a combination of one or two reverse transcriptase inhibitors, and one or two protease inhibitors; 541 patients (25.1%) had never received such treatment. The physician's perception that the patient would not comply with treatment was one reason for not prescribing HAART to 20% of these patients (110). Physicians indicated that the most common reasons for the patient to refuse HAART were the fear of side effects (18%) and the patient's perception that treatment was too complicated (18%). Among 126 patients (5.8%) no longer receiving HAART, the most common reasons for discontinuing treatment were actual side effects (61%) or the fear of side effects (25%). Overall, 16% of patients did not receive therapy in accord with official Swiss guidelines. Multivariate logistic regression analysis indicated that patients with lower education, active intravenous drug users outside of a drug substitution program, and those who acquired HIV infection through intravenous drug use had a significantly higher risk of inadequate treatment. The physician's judgment of patient adherence and the physician's perception of the patient's fear of side effects are critical for the prescription of HAART. Physicians should address these issues to prevent unilateral withholding of treatment and increase the proportion of patients who may benefit from current antiretroviral therapy.
Collapse
Affiliation(s)
- S Bassetti
- Outpatient Department of Internal Medicine, University Hospital, Basel, Switzerland
| | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Bassetti S. [Chronic cough in AIDS]. Praxis (Bern 1994) 1998; 87:1265-1267. [PMID: 9793419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Affiliation(s)
- S Bassetti
- Medizinische Universitätspoliklinik, Departement für Innere Medizin, Kantonsspital Basel
| |
Collapse
|
37
|
Affiliation(s)
- S Bassetti
- Division of Infectious Diseases, Kantonsspital Basel, University Clinics, Switzerland
| | | | | |
Collapse
|
38
|
Bassetti S. [Psychosis in AIDS]. Praxis (Bern 1994) 1998; 87:665-666. [PMID: 9617215] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Affiliation(s)
- S Bassetti
- Departement für Innere Medizin, Kantonsspital Basel
| |
Collapse
|
39
|
Bassetti S, Lyrer P. [Amnesia. Transient global amnesia]. Praxis (Bern 1994) 1997; 86:1565-1566. [PMID: 9417574] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Affiliation(s)
- S Bassetti
- Medizinische Universitätspoliklinik, Kantonsspital Basel
| | | |
Collapse
|
40
|
Bassetti S. [Chronic cough without expectoration]. Praxis (Bern 1994) 1997; 86:1220-1221. [PMID: 9340711] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Affiliation(s)
- S Bassetti
- Department für Innere Medizin, Kantonsspital Basel
| |
Collapse
|
41
|
Bassetti S, Courvoisier S, Itin P. [Oral ulcers in HIV infection]. Praxis (Bern 1994) 1997; 86:912-913. [PMID: 9244978] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Affiliation(s)
- S Bassetti
- Medizinische Universitätspoliklinik, Kantonsspital Basel
| | | | | |
Collapse
|
42
|
Bassetti S, Kober L, Martina B, Zimmerli W. [Chest pain and fever]. Praxis (Bern 1994) 1997; 86:762-766. [PMID: 9244965] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
A 26 year old women was seen at our outpatient clinic because of fever, dyspnea, chest pain and night sweats. An echocardiography revealed a moderate pericardial effusion. Therapy with a nonsteroidal anti-inflammatory drug was started, but the patient did not improve clinically. A new left pleural effusion became manifest. Usual laboratory tests, serological tests and examination of pleural effusion were not conclusive. However, a tuberculin skin test was positive. The etiologic diagnosis of this pericarditis and pleuritis was obtained by thoracoscopic pleural biopsy, which yielded Mycobacterium tuberculosis.
Collapse
Affiliation(s)
- S Bassetti
- Medizinische Universitäts-Poliklinik, Departement Innere Medizin, Kantonsspital, Basel
| | | | | | | |
Collapse
|
43
|
Bassetti S. [Cytomegalovirus colitis in AIDS]. Praxis (Bern 1994) 1997; 86:630-631. [PMID: 9213917] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Affiliation(s)
- S Bassetti
- Medizinische Universitäts-Poliklinik, Departement für Innere Medizin, Kantonsspital Basel
| |
Collapse
|
44
|
Sudre P, Rieder H, Bassetti S, Hirschel B, Ledergerber B, Malvy D. [Tuberculin test, antitubercular chemoprophylaxis and incidence of tuberculosis in a Swiss HIV cohort study]. Rev Epidemiol Sante Publique 1997; 45:171-3. [PMID: 9221445] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
|
45
|
Abstract
BACKGROUND/AIMS The hepatitis G virus is a newly discovered RNA virus which is possibly transmitted parenterally. Hepatitis G virus is associated with acute or chronic hepatitis and may lead to cirrhosis and liver cancer, characteristics shared by the hepatitis C virus. Hepatitis C virus is prevalent in drug users, but the frequency and role of hepatitis G virus is not yet well established. METHODS One hundred and seventeen heavy i.v. drug users were enrolled in a prospective, controlled, randomized study for i.v. administration of heroin and/or methadone. Hepatitis G virus was detected using a hot start polymerase chain reaction followed by an ELISA polymerase chain reaction assay. Hepatitis C virus genotyping was done using the Inno-Lipa strip assay. RESULTS Hepatitis G virus infection was detected in 35% (41/117) of the study population and hepatitis C virus infection in 95.7% (112/117). Ninety-seven percent of hepatitis G virus positive patients were coinfected with hepatitis C virus, of whom 75% were infected with hepatitis C virus genotype 3a. This genotype was prevalent in 48.3% of patients infected with hepatitis C virus alone. The presence or absence of hepatitis G virus infection had no influence on chronic hepatitis. Twenty-two percent of patients who started injecting heroin before 1980 and 40% of those who started after 1980 were hepatitis G virus positive. Overall, 16 patients were infected with human immunodeficiency virus, six were coinfected with hepatitis G virus and hepatitis C virus, and 10 only with hepatitis C virus. CONCLUSIONS Hepatitis G virus infection is highly prevalent in i.v. drug users, but less frequent than hepatitis C virus infection. The fact that all but two patients were coinfected with hepatitis C virus, 75% with one genotype, supports a common route of transmission for both viruses. The course of hepatitis C virus infection is not altered by hepatitis G virus infection.
Collapse
Affiliation(s)
- I Diamantis
- Outpatient Department of Internal Medicine, University of Basel, Switzerland
| | | | | | | | | | | |
Collapse
|
46
|
|
47
|
Bassetti S. [Recurrent dyspnea attacks, urticaria, epigastric symptoms and eosinophilia]. Praxis (Bern 1994) 1997; 86:264-265. [PMID: 9139347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Affiliation(s)
- S Bassetti
- Medizinische Universitätspoliklinik, Departement Innere Medizin, Kantonsspital Basel
| |
Collapse
|
48
|
Sudre P, Rieder H, Bassetti S, Hirschel BJ, Ledergerber B, Malvy D. [HIV infection, tuberculosis and tuberculin test in Switzerland. The Swiss HIV Cohort Study]. Schweiz Med Wochenschr 1996; 126:2007-12. [PMID: 8984608] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
BACKGROUND The usefulness of the tuberculin skin test (TST) for HIV-infected subjects may be questioned because false-negative results are increasingly common with advanced immune deficiency. The objectives of this research were thus to describe the use and the results of TST among patients with HIV infection in Switzerland and to measure the usefulness of isoniazid preventive chemotherapy and the incidence of tuberculosis (TB) relative to TST and CD4 cell count at the time of TST. DESIGN Prospective multicentric cohort study of HIV infected patients; comparison of patients tested and non-tested, and of those with positive and negative TST. Multivariate comparison (Cox model) of TB incidence taking into account TST results and CD4 cell count at the time of TST. RESULTS Out of 5802 patients followed up in the Swiss HIV cohort study as of September 1994, 34.6% were tested. Native Swiss were more likely to be tested than patients from high TB prevalence countries (36% vs 21% of native Africans). Patients registered after 1990 were more often tested than before (50% vs 26%). Of 2010 tested patients, 6.8% had a > 5 mm induration. African patients were more frequently TST positive (26%) than Swiss nationals (6%). Among patients with CD4 > 500 per mm3 at the time of the test, 16% were TST positive compared to 1% of those with CD4 < 200 per mm3. Out of 25 cases of tuberculosis among tested patients, 84% (21) occurred among TST-negative patients. Tuberculosis incidence among TST-negative patients with CD4 > or = 200 per mm3 at the time of the test was 0.3 per person-year. In comparison, the adjusted relative risk of tuberculosis among TST-positive patients with CD4 > or = 200 per mm3 was 5.5 (95% confidence interval [CI]: 1.2-23.9) and 6.6 (CI: 2.3-19.0) among TST-negative patients with CD4 < 200 per mm3. CONCLUSION Despite its usefulness, TST is often performed too late and is therefore difficult to interpret. TST should be done as early as possible. TST should be done as early as possible. Among patients with CD4 < 200 per mm3, a negative TST should not preclude the use-of preventive chemotherapy, particularly in those originally from countries with a high incidence of tuberculosis.
Collapse
Affiliation(s)
- P Sudre
- Division des maladies infectieuses, Hôpital universitaire de Genèva, France
| | | | | | | | | | | |
Collapse
|
49
|
Bassetti S. [A case from practice (361). Acute pancreatitis in AIDS. idiopathic. In microscopic gallstones. (Cotrimoxazole-induced). (In cryptosporidiosis)]. Praxis (Bern 1994) 1996; 85:1493-1494. [PMID: 8984573] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Affiliation(s)
- S Bassetti
- Medizinische Universitätspoliklinik, Kantonsspital Basel
| |
Collapse
|
50
|
Bassetti S. [A case from practice (356). HIV-encephalopathy and vacuolar myelopathy in stage CDC C3 HIV infection]. Praxis (Bern 1994) 1996; 85:1096-1097. [PMID: 8927883] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Affiliation(s)
- S Bassetti
- Medizinische Universitätspoliklinik, Kantonsspital Basel
| |
Collapse
|